At its meeting on 18 October 2016 the Medical Sciences Board:
- Discussed the review that was taking place of the University’s Employer-Justified Retirement Age procedures and agreed that on balance it supported the maintenance of an EJRA for academic and related staff and the examination of ways of ensuring that it operated effectively.
- Received an oral report on Athena SWAN issues, noting amongst other things that it had recently been announced that Oncology and Surgical Sciences had been successful in their applications for Silver awards and the Steering Group had identified a number of likely constraints in respect of a possible combined, divisional submission.
- Received the report of the meeting of the Finance and Physical Capital Committee held on 11 October and agreed to endorse the views of the committee regarding the proposed Institute of Developmental and Regenerative Medicine (following the assessment of academic and business cases for the Institute and in view of the strategic importance of making a major move in this field, with substantial support from the British Heart Foundation); and regarding the case for the proposed Old Road development that would accommodate the Bioescalator and several other activities (provided that the business case for the development showed it to be sustainable).
- Received and noted the reports of the meetings of the Research and Innovation Committee held on 11 October 2016 and the Information Technology Committee held on 22 September 2016.
- Received the report of the Information Security Working Group held on 17 August 2016 and agreed to adopt the working group’s recommendation about information security training, namely that department heads be asked to decide whether they were satisfied with the widespread lack of awareness of key information security issues implied by data on completion of IS training within the Division; and that Heads be asked to ensure as a matter of divisional policy that all new starter employees undertake on-line IS training and that this be repeated annually.
At its meeting on 6 December 2016 the Board:
- Was advised by the Vice-Chancellor of Professor Buchan’s appointment to lead on the University’s Brexit Strategy and of the need therefore to identify an Interim Head of Division. The Board agreed to support the appointment of Professor Chris Kennard in this capacity. The Board further agreed to discuss at its meeting in January 2017 the draft job description and further particulars on the basis of which, subject to Council’s agreement, the next substantive appointment to the Headship of Division would be made as soon as might be arranged in 2017.
- Received a brief oral update on Athena SWAN developments.
- Received and considered the report of the meeting of the Educational Policy and Standards Committee held on 25 November 2016. It was reported that Professor Vaux planned to convene a small group, including college medical tutors, to discuss the need to adopt a consistent approach to making clear the possibility of migration between years 3 and 4; that two proposals for increasing student number had been submitted to the Vice-Chancellor’s Strategy Group and that confirmation of next steps was awaited; that work was proceeding to develop the Graduate Entry Medical Course, taking account of the recommendations of the review that had taken place in September 2015; that a positive though not unconditional response had been submitted to HEFCE following its call for expressions of interest in increasing medical student numbers from 2018; that the committee had given approval on behalf of the Board to submit to Council’s Education Committee a proposal for a new part-time DPhil in Clinical Medicine and also a request to suspend the MSc in Endovascular Neurosurgery; and that there would be a full consultation on the allocation mechanism for MRC DTP studentship funding.
- Received and considered the report of the Finance and Physical Capital Committee held on 21 November 2016, noting that the committee would be revisiting the terms that the MRC was seeking to apply to the competition for Dementia Research Institute centres; and that PRAC’s Capital Steering Group had decided to support, with a substantial capital allocation, the proposed RPIF application in respect of the Institute of Developmental and Regenerative Medicine.
- Noted the reports of the Information Technology Committee held on 24 November 2016 and of the Research and Innovation Committee held on 21 November 2016.
- Discussed the terms of reference of the Oxford University Clinic Project Board that had been agreed by the Strategic Partnership Board (with the Oxford University Hospitals NHS Foundation Trust) and agreed that they should be amended to make clear that any recommendations that might come forward in due course should, within the University, in the first instance be submitted to the Medical Sciences Board for consideration. It was reported that a key aim of the Project Board was to make recommendations regarding whether a joint venture between the University and the Trust, perhaps in collaboration with third parties, might facilitate access to cutting edge medical technologies that would not in the foreseeable future be available locally within the NHS.
To view the current and past agenda/papers, please contact Dr David Bryan.